Therapeutic drug monitoring guides the management of patients with chronic non-infectious uveitis treated with adalimumab: a retrospective study.

Lucas SejournetSebastien KereverThibaud MathisLaurent KodjikianYvan JamillouxPascal Sève

Published in: The British journal of ophthalmology (2021)

TDM of ADA treatment proved relevant to provide CNIU patients with a personalised and optimised treatment course (in terms of frequency and type of drug).

Keyphrases

rheumatoid arthritis
emergency department
combination therapy
systemic lupus erythematosus
adverse drug
drug induced
electronic health record